In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.Read More
Science Market Update
Tags: Stem cell research, Human Stem Cell, Texas Medical Center, Biomedical Reearch, TAMU, tmc, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution
In the aftermath of Hurricane Harvey, a group of researchers will study the effects of the pollution stirred up by the flooding. Scientists from Texas A&M, College Station will conduct four environmental research projects thanks to a five year, $10 million grant from the National Institute of Environmental Health Sciences (NIEHS) Superfund Research Program. All four projects will stem from a case study of Galveston Bay and the Houston Ship Channel that examines the chemicals found within the sediment. These studies are designed to improve our understanding of the complexities of hazardous chemicals exposure and its negative impacts on health.Read More
Tags: environmental contaminants, TAMU, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution
The chancellor’s office of Texas A&M University (TAMU) recently funded a $5 million initiative to support mass spectrometry research. As part of this initiative a $1 million grant from the Texas A&M University Research Development Fund will be used to develop a shared mass spectrometry core facility and buy two new mass spectrometers for the College Station campus. One will be a gas chromatography combustion/pyrolysis isotope ratio mass spectrometer and the other will be a high resolution isotope ratio mass spectrometer for clumped isotopes.Read More
Currently, doctors have two options when a patient needs a facial bone replaced due to injury or illness, such as cancer. They can take a bone from another part of the body and graft it into place. However, implant morbidity and complications caused by the trauma of multiple surgeries make this option less than ideal. The second option is to graft synthetic materials to the site. However, from time of injury to delivery of the custom implant takes about three to four weeks, which reduces the chances of the patient healing properly. But now a new technology being developed by researchers at Texas A&M’s College of Dentistry may revolutionize the treatment process.Read More
For both dairy and beef production, cows are an important part of the US economy and food supply. When they get sick, it's bad for business (and not too pleasant for the cow). The most common illness in cattle is Bovine Respiratory Disease (BRD), which accounts for losses of more than $690M annually in the US alone. To combat this threat to bovine health and productivity, the USDA has recently awarded a $9M 5-year grant to researchers at Texas A&M University's College of Veterinary Medicine and Biomedical Sciences, in collaboration with colleagues at the University of Missouri, to study genetic selection for breeding more disease-resitant stock. A second $5M grant will go towards research into feed efficiency, again with the aim of breeding heartier, healthier, and more profitable animals.
Often growing up as a child you hear, “eat your veggies if you want to grow up to be big and strong.” With new research on triple negative breast cancer, that old saying might have to change to "eat your veggies if you want to keep cancer away". Recently, at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Mandip Sachdeva announced: "We are confident that the compounds we are currently working with are an effective treatment for triple-negative breast cancer. These compounds are safer for the patient than current treatments available".
Tags: Bioscience research, cancer research, Texas A&M University, Texas, 2012, Cancer Treatment, Cancer, College Station, BioResearch Product Faire Event, Texas A&M Research, Texas A&M Life Science Funding, TX, Texas A&M